NCT07502976Recruiting
Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia
Efficacy & Safety of Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution in Treatment of Androgenetic Alopecia: A Clinical & Biochemical Randomized Controlled Trial
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Kasr El Aini Hospital
- Participants (registry)
- 60
- Start
- January 2026
- Primary completion
- October 2026
- Study completion
- January 2027 (planned)
- Last registry update
- April 2026
- Countries
- Egypt
Conditions studied: Androgenic Alopecia
Interventions: Topical 2-Deoxy-D-ribose Hydrogel, Topical Minoxidil 5% Solution
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.